Identifying the Role of Clinical Biomarkers in Genome Editing Therapeutics for Sickle Cell Disease

Time: 3:00 pm
day: Day Two

Details:

  • Biomarkers to support efficacy of gene editing therapies to treat sickle cell disease
  • Specialized biomarker discovery to assess disease pathophysiology
  • Importance and opportunity biomarkers bring to accelerate clinical development

Speakers: